Oncology Institute (TOI) Net Cash Flow (2020 - 2026)

Oncology Institute (TOI) has reported Net Cash Flow for 7 consecutive years, with -$3.3 million the latest figure, recorded in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$3.3 million, up 66.92% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.5 million (down 370.41% YoY), and the FY2025 annual result was -$16.1 million, down 199.52% from the prior year.
• Net Cash Flow was -$3.3 million for Q1 2026 at Oncology Institute, down from $5.9 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $13.6 million in Q2 2023 and troughed at -$47.4 million in Q4 2022.
• Average Net Cash Flow over 5 years is -$5.0 million, with a median of -$1.4 million recorded in 2023.
• Year-over-year, Net Cash Flow soared 908.99% in 2024 and plunged 2660.16% in 2025.
• Over 5 years, Net Cash Flow stood at -$47.4 million in 2022, then soared by 112.56% to $6.0 million in 2023, then sank by 65.04% to $2.1 million in 2024, then soared by 183.85% to $5.9 million in 2025, then plunged by 155.61% to -$3.3 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$3.3 million in Q1 2026, $5.9 million in Q4 2025, and -$2.6 million in Q3 2025.